p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
Author(s)
Type
Journal Article
Date Issued
1998-03-01
ISSN
0007-0920
Publisher
CHURCHILL LIVINGSTONE
Start Page
776
End Page
782
Journal / Book Title
BRITISH JOURNAL OF CANCER
Volume
77
Issue
5
Copyright Statement
© 1998 Cancer Research Campaign. This article is avaialble under a Creative Commons Attribution Non-Commercial Share Alike License (https://creativecommons.org/licenses/by-nc-sa/2.5/)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072354000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
liver carcinoma
oncosuppressor gene
hepatitis
cirrhosis
FIBROLAMELLAR CARCINOMA
CELL-LINES
GENE
DNA
LIVER
P53-GENE
ANTIGEN
OCCUR
Adolescent
Adult
Aged
Biomarkers, Tumor
Carcinoma, Hepatocellular
Codon
DNA Mutational Analysis
DNA, Neoplasm
Electrophoresis, Polyacrylamide Gel
Exons
Female
Genes, p53
Hepatectomy
Hepatitis B
Hepatitis C
Humans
Life Tables
Liver Cirrhosis
Liver Cirrhosis, Alcoholic
Liver Neoplasms
Male
Middle Aged
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
Prognosis
Survival Analysis
Tumor Markers, Biological
Oncology & Carcinogenesis
1112 Oncology And Carcinogenesis
Publication Status
Published